Is Standrew (WSE:STD) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies Standrew S.A. (WSE:STD) makes use of debt. But the more important question is: how much risk is that debt creating?

Advertisement

What Risk Does Debt Bring?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. If things get really bad, the lenders can take control of the business. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

View our latest analysis for Standrew

What Is Standrew's Net Debt?

As you can see below, Standrew had zł9.82m of debt at December 2021, down from zł11.0m a year prior. However, it also had zł324.1k in cash, and so its net debt is zł9.49m.

debt-equity-history-analysis
WSE:STD Debt to Equity History April 4th 2022

How Healthy Is Standrew's Balance Sheet?

According to the last reported balance sheet, Standrew had liabilities of zł8.97m due within 12 months, and liabilities of zł4.02m due beyond 12 months. Offsetting these obligations, it had cash of zł324.1k as well as receivables valued at zł2.95m due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by zł9.71m.

This is a mountain of leverage relative to its market capitalization of zł11.4m. This suggests shareholders would be heavily diluted if the company needed to shore up its balance sheet in a hurry.

In order to size up a company's debt relative to its earnings, we calculate its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and its earnings before interest and tax (EBIT) divided by its interest expense (its interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

Standrew has a debt to EBITDA ratio of 4.8 and its EBIT covered its interest expense 3.2 times. Taken together this implies that, while we wouldn't want to see debt levels rise, we think it can handle its current leverage. The silver lining is that Standrew grew its EBIT by 138% last year, which nourishing like the idealism of youth. If it can keep walking that path it will be in a position to shed its debt with relative ease. There's no doubt that we learn most about debt from the balance sheet. But it is Standrew's earnings that will influence how the balance sheet holds up in the future. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

Finally, while the tax-man may adore accounting profits, lenders only accept cold hard cash. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. Over the last three years, Standrew reported free cash flow worth 8.9% of its EBIT, which is really quite low. That limp level of cash conversion undermines its ability to manage and pay down debt.

Our View

To be frank both Standrew's conversion of EBIT to free cash flow and its track record of managing its debt, based on its EBITDA, make us rather uncomfortable with its debt levels. But at least it's pretty decent at growing its EBIT; that's encouraging. Looking at the balance sheet and taking into account all these factors, we do believe that debt is making Standrew stock a bit risky. Some people like that sort of risk, but we're mindful of the potential pitfalls, so we'd probably prefer it carry less debt. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. To that end, you should learn about the 4 warning signs we've spotted with Standrew (including 1 which doesn't sit too well with us) .

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

M
mitchell_lawler
mitchell_lawler

When oil spikes, crude gets the attention. I think the boring refiner in the middle is where it gets interesting, and a record shows why.

56
Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85

About WSE:STD

Standrew

Engages in the timber industry in Europe.

Slight risk and slightly overvalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.576.0% undervalued
46 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
AN
andrei9868
Emerging Author
NOW logo
andrei9868 on ServiceNow ·

The Platform Turning Enterprise Chaos into Autonomous Workflows

Fair Value:US$17015.9% undervalued
25 users have followed this narrative
2 users have commented on this narrative
5 users have liked this narrative
JO
John_Eric
Emerging Author
VST logo
John_Eric on Vistra ·

Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.

Fair Value:US$291.8752.7% undervalued
13 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HA
HarishPK
Emerging Author
EVER logo
HarishPK on EverQuote ·

EverQuote and an Asymmetric Investment Opportunity

Fair Value:US$36.0931.2% undervalued
6 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

TR
TripleS
SGMO.Q logo
TripleS on Sangamo Therapeutics ·

Likely recovery of 2.5X over the current stock price of Sangamo assuming milestone payments are successful

Fair Value:US$0.3654.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DE
Deep_Insights
HIMS logo
Deep_Insights on Hims & Hers Health ·

Hims & Hers Health Multidimensional Revenue Expansion

Fair Value:US$171.1983.4% undervalued
73 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
StoxEurope
UCB logo
StoxEurope on UCB ·

FV 206,24 but with a 310-154 range...to discuss

Fair Value:€227.494.0% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
375 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.2% undervalued
128 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.3% overvalued
220 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Trending Discussion